KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Equity (2018 - 2025)

Moderna (MRNA) has disclosed Return on Equity for 8 consecutive years, with 0.31% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.31% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.31%, a 0.0% change, with the full-year FY2025 number at 0.29%, changed 0.0% from a year prior.
  • Return on Equity was 0.31% for Q4 2025 at Moderna, up from 0.33% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.01% in Q4 2021 to a low of 0.62% in Q2 2025.
  • A 5-year average of 0.1% and a median of 0.06% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: skyrocketed 129bps in 2021, then crashed -88bps in 2023.
  • Moderna's Return on Equity stood at 1.01% in 2021, then tumbled by -55bps to 0.45% in 2022, then tumbled by -177bps to 0.35% in 2023, then rose by 10bps to 0.31% in 2024, then decreased by -1bps to 0.31% in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Return on Equity are 0.31% (Q4 2025), 0.33% (Q3 2025), and 0.62% (Q2 2025).